Increased intensity plus adherence maximises statin benefits
High adherence to intensive lipid-lowering therapy provides the greatest risk reduction for cardiovascular events, a study in JAMA Network Open has shown.
Source: Clinical Pharmacist - Category: Drugs & Pharmacology Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Drugs & Pharmacology | Heart | Statin Therapy | Study